Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




$29 Billion In Vitro Diagnostics Market Seen for 2007

By HospiMedica staff writers
Posted on 13 Feb 2002
The in vitro diagnostics (IVD) market generated revenues of nearly US$20 billion in 2000 and is projected to surge to more than $29 billion by 2007, according to a new analysis from Frost & Sullivan entitled "World In Vitro Diagnostic Technologies Markets.”

In vitro diagnostics offer early, accurate diagnosis of diseases, but a lack of comprehensive laboratory automation has slowed the evolution of absolute efficiency, according to Frost and Sullivan's analysis. More...
While automation has made important progress in recent years, there is a strong, often-overlooked need for automation in laboratory specimen processing, prioritizing, and preparation. The workload in this part of the IVD system is often erratic, making it a difficult section to automate. As a result, operations may slow down and experience delays that interrupt the smooth flow necessary for overall efficiency. Eventually, this results in a bottleneck within the processing section, and this constriction may cause inefficiency within other parts of the IVD procedures.

"In order to improve laboratory efficiency, efforts should be made to develop at least a partially automated system for the processing section,” said Frost & Sullivan analyst Kelly Westfall. "Until a reliable system can be integrated in processing, facilities will not fully realize how effectively their current automated workstations are operating.”




Related Links:
Frost & Sullivan

Gold Member
Blood Gas Analyzer
Stat Profile pHOx
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Laboratory Software
ArtelWare
Capillary Blood Collection Tube
IMPROMINI M3
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.